Literature DB >> 28647165

Modelling efforts needed to advance herpes simplex virus (HSV) vaccine development: Key findings from the World Health Organization Consultation on HSV Vaccine Impact Modelling.

Sami L Gottlieb1, Birgitte Giersing2, Marie-Claude Boily3, Harrell Chesson4, Katharine J Looker5, Joshua Schiffer6, Ian Spicknall4, Raymond Hutubessy2, Nathalie Broutet2.   

Abstract

Development of a vaccine against herpes simplex virus (HSV) is an important goal for global sexual and reproductive health. In order to more precisely define the health and economic burden of HSV infection and the theoretical impact and cost-effectiveness of an HSV vaccine, in 2015 the World Health Organization convened an expert consultation meeting on HSV vaccine impact modelling. The experts reviewed existing model-based estimates and dynamic models of HSV infection to outline critical future modelling needs to inform development of a comprehensive business case and preferred product characteristics for an HSV vaccine. This article summarizes key findings and discussions from the meeting on modelling needs related to HSV burden, costs, and vaccine impact, essential data needs to carry out those models, and important model components and parameters.
Copyright © 2017. Published by Elsevier Ltd.

Entities:  

Keywords:  HSV vaccines; Herpes simplex virus; Modelling; Sexually transmitted infections

Mesh：

Substances：

Year:  2017        PMID： 28647165     DOI： 10.1016/j.vaccine.2017.03.074

Source DB:  PubMed          Journal:  Vaccine        ISSN： 0264-410X            Impact factor:   3.641


  15 in total

1.  Gonococcal vaccines: Public health value and preferred product characteristics; report of a WHO global stakeholder consultation, January 2019.

Authors:  Sami L Gottlieb; Francis Ndowa; Edward W Hook; Carolyn Deal; Laura Bachmann; Laith Abu-Raddad; Xiang-Sheng Chen; Ann Jerse; Nicola Low; Calman A MacLennan; Helen Petousis-Harris; Kate L Seib; Magnus Unemo; Leah Vincent; Birgitte K Giersing
Journal:  Vaccine       Date:  2020-04-28       Impact factor: 3.641

2.  Characterizing herpes simplex virus type 1 and type 2 seroprevalence declines and epidemiological association in the United States.

Authors:  Hiam Chemaitelly; Nico Nagelkerke; Ryosuke Omori; Laith J Abu-Raddad
Journal:  PLoS One       Date:  2019-06-06       Impact factor: 3.240

3.  Herpes simplex virus type 1 epidemiology in Latin America and the Caribbean: Systematic review and meta-analytics.

Authors:  Layan Sukik; Maryam Alyafei; Manale Harfouche; Laith J Abu-Raddad
Journal:  PLoS One       Date:  2019-04-22       Impact factor: 3.240

4.  Herpes simplex virus type 1 epidemiology in the Middle East and North Africa: systematic review, meta-analyses, and meta-regressions.

Authors:  Sonia Chaabane; Manale Harfouche; Hiam Chemaitelly; Guido Schwarzer; Laith J Abu-Raddad
Journal:  Sci Rep       Date:  2019-02-04       Impact factor: 4.379

5.  Negative epidemiological association between HSV-1 and HSV-2 infections.

Authors:  Gheyath K Nasrallah; Soha R Dargham; Laith J Abu-Raddad
Journal:  Heliyon       Date:  2019-10-23

6.  Engineering Requirements of a Herpes Simplex Virus Patient Registry: Discovery Phase of a Real-World Evidence Platform to Advance Pharmacogenomics and Personalized Medicine.

Authors:  Svitlana Surodina; Ching Lam; Caroline de Cock; Michelle van Velthoven; Madison Milne-Ives; Edward Meinert
Journal:  Biomedicines       Date:  2019-12-15

Review 7.  Review of mathematical models of HSV-2 vaccination: Implications for vaccine development.

Authors:  Ian H Spicknall; Katharine J Looker; Sami L Gottlieb; Harrell W Chesson; Joshua T Schiffer; Jocelyn Elmes; Marie-Claude Boily
Journal:  Vaccine       Date:  2018-04-04       Impact factor: 3.641

8.  Herpes simplex virus type 1 in Europe: systematic review, meta-analyses and meta-regressions.

Authors:  Wajiha Yousuf; Hania Ibrahim; Manale Harfouche; Farah Abu Hijleh; Laith Abu-Raddad
Journal:  BMJ Glob Health       Date:  2020-07

9.  The global and regional burden of genital ulcer disease due to herpes simplex virus: a natural history modelling study.

Authors:  Katharine Jane Looker; Christine Johnston; Nicky J Welton; Charlotte James; Peter Vickerman; Katherine M E Turner; Marie-Claude Boily; Sami L Gottlieb
Journal:  BMJ Glob Health       Date:  2020-03-08

10.  Analytic Characterization of the Herpes Simplex Virus Type 2 Epidemic in the United States, 1950-2050.

Authors:  Houssein H Ayoub; Ibtihel Amara; Susanne F Awad; Ryosuke Omori; Hiam Chemaitelly; Laith J Abu-Raddad
Journal:  Open Forum Infect Dis       Date:  2021-04-29       Impact factor: 3.835
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.